{"abstract":"The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Commercialization Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the Summary Information section of this notice to Microbiotix, Inc. (\"Microbiotix\") located in Worcester, Massachusetts.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2017/02/09/2017-02673.html","cfr_references":[],"citation":"82 FR 10025","comment_url":null,"comments_close_on":"2017-02-24","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the National Institute of Allergy and Infectious Diseases' Technology Transfer and Intellectual Property Office on or before February 24, 2017 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2017-02673","effective_on":null,"end_page":10025,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2017/02/09/2017-02673.xml","html_url":"https://www.federalregister.gov/documents/2017/02/09/2017-02673/prospective-grant-of-exclusive-patent-license-inhibition-of-plasmodial-surface-anion-channels-for","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2017-02673?publication_date=2017-02-09","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2017-02-09/2017-02673/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":97,"last_updated":"2026-10-24 00:15:05 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2017-02-09/pdf/2017-02673.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2017-02673.pdf?1486561557","publication_date":"2017-02-09","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2017/02/09/2017-02673.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-03-01T00:22:49Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":10025,"subtype":null,"title":"Prospective Grant of Exclusive Patent License: Inhibition of Plasmodial Surface Anion Channels for the Treatment or Prevention of Malaria","toc_doc":"Inhibition of Plasmodial Surface Anion Channels for Treatment or Prevention of Malaria","toc_subject":"Exclusive Patent Licenses:","topics":[],"type":"Notice","volume":82}